SCHEMBL8214568

SCHEMBL8214568

CC(C)(C)S(=O)(=O)C(C)(C)c1cc(N2CCOCC2)nc(Cl)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 2/20 0.49
PIK3CA P42336 3/20 0.46
MTOR P42345 1/20 0.46
ATR Q13535 1/20 0.46
POLB P06746 1/20 0.43
KMT2A Q03164 4/20 0.43
MAPT P10636 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 1/20 0.42
NPSR1 Q6W5P4 3/20 0.41
AKT1 P31749 1/20 0.41
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
PIK3R1 P27986 1/20 0.39
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3588100 0.88 PIK3CA (0.54) HRH4PIK3CAMTORATRPOLB
SCHEMBL3592743 0.82 PIK3CA (0.54) PIK3CAATRPIK3R1
SCHEMBL8219150 0.82 HRH4 (0.44) HRH4PIK3CAMTORATRPOLB
SCHEMBL3404233 0.80 HRH4 (0.55) HRH4PIK3CAATRPOLBKMT2A
SCHEMBL8217236 0.79 PIK3CA (0.44) HRH4PIK3CAMTORATRPOLB
SCHEMBL856718 0.75 MAPT (0.61) HRH4PIK3CAPOLBKMT2AMAPT
SCHEMBL2489923 0.73 POLB (0.55) PIK3CAMTORATRPOLBKMT2A
SCHEMBL3592915 0.72 PIK3CA (0.51) PIK3CAMTORATRPIK3R1
SCHEMBL2531188 0.71 KMT2A (0.68) HRH4KMT2AMAPTCYP1A2CYP2D6
SCHEMBL1271807 0.71 MTOR (0.65) PIK3CAMTORATRPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008023159-A1 MORPHOLINO PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2008-02-28 WO disclosed